Dr. Kai MacDonald’s Publications from 1998–2017 | Kai MacDonald, MD | Office located in San Diego

  • 1998-2017

    MacDonald, K., & Pappas, K. (2016). Why Not Pot: A Review of the Brain-Based Risks of Cannabis. Innovations in clinical neuroscience, 13(3-4), 13-23.

    MacDonald, K., Thomas, M. L., Sciolla, A. F., Schneider, B., Pappas, K., Bleijenberg, G., . . . Wingenfeld, K. (2016). Minimization of Childhood Maltreatment Is Common and Consequential: Results from a Large, Multinational Sample Using the Childhood Trauma Questionnaire. PloS one, 11(1), e0146058. doi: 10.1371/journal.pone.0146058

    MacDonald, K., Lamb, K., Thomas, M. L., & Khentigan, W. (2016). Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices. Substance use & misuse, 51(1), 85-90. doi: 10.3109/10826084.2015.1089905

    MacDonald, K., Andrés F. Sciolla, David Folsom, David Bazzo, Chris Searles, Christine Moutier, Michael L. Thomas, Katherine Borton, Bill Norcross. (2015) Corrigendum to “Individual risk factors for physician boundary violations: the role of attachment style, childhood trauma, and maladaptive beliefs.” [Gen Hosp Psychiatry 37/1 81–88]

    Feifel, D., P.D. Shilling and K. MacDonald. (2015). “A Review of Oxytocin’s Effects on the Positive, Negative and Cognitive Domains of Schizophrenia. Biological Psychiatry.” Biological psychiatry 79(3): 222-233..

    MacDonald, K., A.F. Sciolla, D. Folsom, D. Bazzo, C.
    Searles, C. Moutier, et al. (2015). “Individual risk factors for physician
    boundary violations: The role of attachment style, childhood trauma and
    maladaptive beliefs.” General hospital psychiatry, 2015. 37(1): p. 81-8.

    Macdonald, K., Ebner, N. C., H. Kamin, et al. (2014).
    “Hormones as “difference makers” in cognitive and socioemotional aging
    processes.” Frontiers in psychology 5: 1595.

    MacDonald, K., Feifel, D. (2014). “Oxytocin’s Role in
    Anxiety: A Critical Appraisal.” Brain Research (2014),

    MacDonald, K, Thomas, M., MacDonald, T. M., Sciolla, A.
    (2014) “A Perfect Childhood? Clinical correlates of minimization and denial
    on the Childhood Trauma Questionnaire.” Journal of Interpersonal Violence
    (In Press).

    Feifel, D. and K. MacDonald (2014). Oxytocin. Encyclopedia
    of Psychopharmacology. I. P. Stolerman and L. H. Price. Heidelberg,

    Wilson MP, Macdonald K, Vilke GM, Ronquillo L, Feifel D.
    Intramuscular Ziprasidone: Influence of alcohol and benzodiazepines on vital
    signs in the emergency setting. J Emerg Med 2013. [Epub 2013 Sep24].

    Ebner, N. C., Maura, G. M., Macdonald, K., Westberg, L., &
    Fischer, H. (2013). Oxytocin and socio-emotional aging: Current knowledge
    and future trends. Frontiers in human neuroscience, 7, 487.

    Macdonald, K., Berlow, R., & Thomas, M. L. (2013). Attachment,
    affective temperament, and personality disorders: A study of their
    relationships in psychiatric outpatients.
    Journal of affective disorders, 151(3), 932-941.

    Macdonald, K., Feifel, D., Brune, M., Lamb, K., Wilson, M. P.,
    Golshan, S., et al. (2013). Not disappointed by anxiety: A reply to Cardoso
    and Ellenbogen’s commentary “Oxytocin and psychotherapy: Keeping context and
    person in mind”. [Letter]. Psychoneuroendocrinology. (2013),

    Macdonald, K., & Feifel, D. (2013). Helping oxytocin deliver:
    considerations in the development of oxytocin-based therapeutics for brain
    disorders. Frontiers in neuroscience, 7, 35.

    Feifel, D., Macdonald, K., Cobb, P., McKinney, R., & Hadley, A.
    (2013). The long-term efficacy and safety of flexibly-dosed adjunctive
    intranasal oxytocin in patients with schizophrenia; an open-label study.
    Biological psychiatry, 73, 320S.

    Kim, D., Bae, H., Han, C., Oh, H. Y., & Macdonald, K. (2013).
    Psychometric properties of the Childhood Trauma Questionnaire-Short Form
    (CTQ-SF) in Korean patients with schizophrenia.
    Schizophrenia research, 144 (1-3), 93-98.

  • 2012-2011 

    MacDonald, K., & Feifel, D. (2012). Oxytocin in schizophrenia: a
    review of evidence for its therapeutic effects.
    Acta neuropsychiatrica. 1-17.

    MacDonald, K., & Feifel, D. (2012). Dramatic improvement in
    sexual function induced by intranasal oxytocin.
    The journal of sexual medicine, 9(5), 1407-1410.

    Wilson, M. P., Chen, N., Vilke, G. M., Castillo, E. M.,
    Macdonald, K., & Minassian, A. (2012). Olanzapine in ED patients:
    differential effects on oxygenation in patients with alcohol intoxication.
    The American journal of emergency medicine.

    MacDonald K,, Wilson MP, Minassian A, Vilke GM, Becker O, Tallian K,
    Cobb P, Perez R, Galangue B, Feifel D. A naturalistic study of intramuscular
    haloperidol versus intramuscular olanzapine for the management of acute
    agitation. J Clin Psychopharm.  32(3):317-322.

    Wilson, M. P., Macdonald, K., Vilke, G. M., & Feifel, D. (2011).
    A Comparison of the Safety of Olanzapine and Haloperidol in Combination with
    Benzodiazepines in Emergency Department Patients with Acute Agitation.
    The Journal of Emergency Medicine.10.1016/j.jemermed.2011.01.024

    MacDonald, K.  Hands on 2:  A trip between banks:  the
    insula and its role in therapeutic transitions: 
    Transformance: the AEDP journal: Issue 1 (2) March, 2011.

    Crean, R, Tapert, S, Minassian, A, MacDonald, K, Crane, N, Mason,
    B.  Effects of Chronic, Heavy Cannabis Use on Executive
    Functions:  Addict Med  2011; 5
    (1): 9-15.

  • 2010-2009 

    MacDonald, K.  Hands On 1: Into the Insula:
    Interoception and the Feeling Self
    : Transformance: the AEDP journal: Issue 1 (1) September, 2010:

    Wilson, M, MacDonald, K, Vilke, G, Feifel, D. Potential Complications
    of Olanzapine + Benzodiazepines Compared to Haloperidol + Benzodiazepines In
    Emergency Department Patients. 
    Annals of Emergency Medicine 2010; 56: 3 (1): S52.

    Wilson, M, MacDonald, K, Vilke, G, Feifel, D.  Potential
    Complications of Combining Intramuscular Olanzepine with Benzodiazepines in
    Emergency Department Patients. 
    The Journal of Emergency Medicine, 2010

    Feifel D, MacDonald K, Nguyen A, Cobb P, Warlan H, Galangue B,
    Minassian A, Becker O, Cooper J, Perry W, Lefebvre M, Gonzales J, Hadley A.
    Adjunctive intranasal oxytocin reduces symptoms in schizophrenia
    Biological Psychiatry 2010:. 1;68(7): 678-80.

    MacDonald K, Wilson M, Minassian A, Vilke G, Perez R, Tallian K,
    Becker O, Feifel D.  A retrospective analysis of intramuscular
    haloperidol versus intramuscular olanzapine for the treatment of agitated
    drug and alcohol-using patients.
    General Hospital Psychiatry 2010; 32(4): 443-445.

    MacDonald, K, MacDonald T.  The Peptide that Binds:  A
    systematic review of oxytocin and its prosocial effects in humans. 
    Harvard Review of Psychiatry 2009; 18(1): 1-21.

    MacDonald K, MacDonald T.  Peas, Please:  A Case Report and
    Neuroscientific Review of Dissociative Amnesia and Fugue. 
    Journal of Trauma and Dissociation 2009; 10(4): 420-35.

    MacDonald K Patient-Clinician Eye Contact: Social Neuroscience and
    the Art of Clinical Engagement. Postgraduate Medicine 2009; Jul;
    121(4): 136-44.

  • 2008-1998

    MacDonald K.  Dissociative disorders unclear?  Think
    ‘rainbows’ from ‘pain blows’.  Current Psychiatry 2008; 7 (5):

    Feifel D, MacDonald K. Attention-deficit/hyperactivity
    disorder in adults: Recognition and diagnosis of this often-overlooked
    condition.  Postgraduate Medicine 2008; 120 (3): 39-47. 

    MacDonald K.  Interoceptive Cues: When ‘Gut Feelings’ Point to
    Anxiety.  Current Psychiatry 2007; 6 (11): 49-62.

    MacDonald K.  Body of evidence: Investigating ‘Gut Feelings’
    with Interoceptive Cues. Current Psychiatry 2007; 6(11): 45-58.

    MacDonald K.  Optimizing Outcome:  Bipolar Disorder and
    Specialist Referral.    Primary Psychiatry 2006; 13
    (6):  52-59.

    Einat H.; Levine J.; Grauer E.; MacDonald K.; Belmaker R.H.  Effect
    of Inositol treatment on the behavior of rhesus monkeys: preliminary results. Progress in neuro-psychopharmacology and biological psychiatry 1998; 22 (6): 999-1005.